PCSK9 binds to and promotes degradation of LDLR, thus regulating serum levels of LDL. An accessible groove in PCSK9, adjacent to the LDLR-binding site, can be targeted by peptides that disrupt the LDLR interaction.
- Yingnan Zhang
- Mark Ultsch
- Daniel Kirchhofer
